Understand the source comparison
Growth Peptides vs Kisspeptin: Anabolic Pathways Are Not Reproductive Pathways
Growth hormone secretagogues like GHRP-2, ipamorelin, and MK-677 (ibutamoren) stimulate GH release by binding ghrelin receptors (GHSR1a) in the anterior pituitary. MK-677 is orally bioavailable and produces sustained elevation in serum GH and IGF-1 over 24 hou
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth hormone secretagogues like GHRP-2, ipamorelin, and MK-677 (ibutamoren) stimulate GH release by binding ghrelin receptors (GHSR1a) in the anterior pituitary. MK-677 is orally bioavailable and produces sustained elevation in serum GH and IGF-1 over 24 hours. Kisspeptin has no ghrelin receptor affinity and doesn't directly stimulate GH secretion.
- The confusion arises because testosterone. Which kisspeptin can indirectly elevate by restoring LH pulsatility. Has anabolic effects. But that mechanism is several steps removed from direct GH pathway activation. In hypogonadal men, kisspeptin administration restored testosterone to physiological levels (400–600 ng/dL baseline), but this doesn't replicate the supraphysiological GH and IGF-1 elevations seen with GHRP protocols. Research in the Journal of Neuroendocrinology confirmed that kisspeptin's anabolic effects are mediated entirely through gonadotropin signaling. Not GH/IGF-1 axis stimulation.
- GHRP-2 has a half-life of approximately 20–30 minutes (similar to kisspeptin-10), but its downstream effects last longer because GH pulses trigger hepatic IGF-1 synthesis that remains elevated for 12–24 hours. Kisspeptin's LH pulse triggers testosterone synthesis, which has a half-life of 2.5–3 hours in circulation. Shorter than IGF-1's 12–15 hour half-life. This means growth peptides produce more sustained anabolic signaling per administration than kisspeptin does for gonadal function.
- Real peptides carries both growth secretagogues and reproductive peptides synthesized under identical USP standards. The molecular integrity is the same, but the biological targets are not.